CAS 614726-85-1

Fórmula: C17H12Cl3N3O

InChI: InChI=1S/C17H12Cl3N3O/c1-9-15(17(21)24)22-23(14-7-6-12(19)8-13(14)20)16(9)10-2-4-11(18)5-3-10/h2-8H,1H3,(H2,21,24)

Chave InChI: BBUKVPCUOHFAQN-UHFFFAOYSA-N

SMILES: CC1=C(N(N=C1C(=O)N)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)Cl

CB1 antagonist 2

CAS: 614726-85-1

CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM.

Fórmula: C₁₇H₁₂Cl₃N₃O

Pureza: 99.75%

Cor e Forma: Solid

Peso molecular: 380.656

Ref: TM-T14881

CB1 antagonist 2

CAS: 614726-85-1

CB1 antagonist 2

Fórmula: C₁₇H₁₂Cl₃N₃O

Pureza: ≥98%

Peso molecular: 380.66

Ref: 54-BUP09890

5-(4-Chlorophenyl)-1-(2,4-Dichlorophenyl)-4-Methyl-1H-Pyrazole-3-Carboxamide

CAS: 614726-85-1

Fórmula: C₁₇H₁₂Cl₃N₃O

Pureza: 98%

Peso molecular: 380.6557

Ref: IN-DA01E4UZ

AM 4113

Produto Controlado

CAS: 614726-85-1

Fórmula: C₁₇H₁₂Cl₃N₃O

Cor e Forma: Neat

Peso molecular: 380.656

Ref: TR-A634670

AM 4113

Produto Controlado

CAS: 614726-85-1

AM 4113 is a fatty acid that can be found in the brain of mice. It is a neutral antagonist to cannabinoid receptors, and has shown to have antidepressant effects. AM 4113 binds to the CB1 receptor, which is responsible for mediating the psychoactive effects of cannabinoids. This compound also has been shown to have anxiolytic-like effects in mice, as well as an increase in locomotor activity. The antidepressant-like effect of this compound may be due to its ability to increase dopamine levels in the brain.

Fórmula: C₁₇H₁₂Cl₃N₃O

Pureza: Min. 95%

Peso molecular: 380.66 g/mol

Ref: 3D-PZA72685